ACM
REPL icon

ACT Capital Management’s Replimune Group REPL Stock Holding History

ACT Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-61,500
Closed -$470K – 72
2026
Q1 		$470K Hold
61,500
– – 0.37% 34
2025
Q4 		$598K Buy
+61,500
New +$523K 0.48% 32

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

ACT Capital Management's REPL Position: Q2 2026 in Review

ACT Capital Management sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 61,500 shares — an estimated $470K sold.

ACT Capital Management first reported a position in REPL in Q4 2025 and held it in 2 quarters. The position peaked at $598K in Q4 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • ACT Capital Management reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • ACT Capital Management sold 61,500 Replimune Group shares in Q2 2026, an estimated $470K.
  • ACT Capital Management first reported a position in Replimune Group in Q4 2025 and held it in 2 quarters.
  • ACT Capital Management's Replimune Group position peaked at $598K in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.